DSpace

DSpace at RU >

Search Results

 
for  

Results 1-50 of 84.

Sort items by In order  |  Results/Page Authors/record

Item hits:

Full TextIssue DateTitleAuthor(s)
2011Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J. Immunol. 1986. 137: 245-254.Dustin, M.L.; Rothlein, R.; Bhan, A.K.; Dinarello, C.A.; Springer, T.A.
2011Anakinra for the inflammatory complications of chronic granulomatous diseaseVeerdonk, F.L. van de; Netea, M.G.; Dinarello, C.A.; Meer, J.W.M. van der
2011More than inflammation: interleukin-1beta polymorphisms and the lipid metabolismNetea, M.G.; Dinarello, C.A.
2011TREM-1 interaction with the LPS/TLR4 receptor complexArts, R.J.; Joosten, L.A.B.; Dinarello, C.A.; Kullberg, B.J.; Meer, J.W. van der; Netea, M.G.
2011Blocking interleukin-1beta in acute and chronic autoinflammatory diseases.Dinarello, C.A.
2011Interplay between redox status and inflammasome activationRubartelli, A.; Gattorno, M.; Netea, M.G.; Dinarello, C.A.
2011Inflammasome activation and IL-1beta and IL-18 processing during infectionVeerdonk, F.L. van de; Netea, M.G.; Dinarello, C.A.; Joosten, L.A.B.
2011IL-1alpha and IL-1beta recruit different myeloid cells and promote different stages of sterile inflammation.Rider, P.; Carmi, Y.; Guttman, O.; Braiman, A.; Cohen, I.; Voronov, E.; White, M.R.; Dinarello, C.A.; Apte, R.N.
2011The oral histone deacetylase inhibitor ITF2357 reduces cytokines and protects islet beta cells in vivo and in vitro.Lewis, E.C.; Blaabjerg, L.; Storling, J.; Ronn, S.G.; Mascagni, P.; Dinarello, C.A.; Mandrup-Poulsen, T.
2011Interleukin-1 in the pathogenesis and treatment of inflammatory diseases.Dinarello, C.A.
2011Inhibition of IL-32 activation by alpha-1 antitrypsin suppresses alloreactivity and increases survival in an allogeneic murine marrow transplantation model.Marcondes, A.M.; Li, X.; Tabellini, L.; Bartenstein, M.; Kabacka, J.; Sale, G.E.; Hansen, J.A.; Dinarello, C.A.; Deeg, H.J.
2011Sterile inflammation of endothelial cell-derived apoptotic bodies is mediated by interleukin-1alpha.Berda-Haddad, Y.; Robert, S.; Salers, P.; Zekraoui, L.; Farnarier, C.; Dinarello, C.A.; Dignat-George, F.; Kaplanski, G.
2011Histone deacetylase inhibitors for treating a spectrum of diseases not related to cancer.Dinarello, C.A.; Fossati, G.; Mascagni, P.
2011Histone deacetylase inhibitors for purging HIV-1 from the latent reservoir.Matalon, S.; Rasmussen, T.A.; Dinarello, C.A.
2011A clinical perspective of IL-1beta as the gatekeeper of inflammation.Dinarello, C.A.
2011The pathogenic Th17 cell response to major schistosome egg antigen is sequentially dependent on IL-23 and IL-1beta.Shainheit, M.G.; Lasocki, K.W.; Finger, E.; Larkin, B.M.; Smith, P.M.; Sharpe, A.H.; Dinarello, C.A.; Rutitzky, L.I.; Stadecker, M.J.
2011Safety and efficacy of an oral histone deacetylase inhibitor in systemic-onset juvenile idiopathic arthritis.Vojinovic, J.; Damjanov, N.; D'Urzo, C.; Furlan, A.; Susic, G.; Pasic, S.; Iagaru, N.; Stefan, M.; Dinarello, C.A.
2011Protection from RNA and DNA viruses by IL-32.Zepp, J.A.; Nold-Petry, C.A.; Dinarello, C.A.; Nold, M.F.
2011IL-32 expression in the airway epithelial cells of patients with Mycobacterium avium complex lung disease.Bai, X.; Ovrutsky, A.R.; Kartalija, M.; Chmura, K.; Kamali, A.; Honda, J.R.; Oberley-Deegan, R.E.; Dinarello, C.A.; Crapo, J.D.; Chang, L.Y.; Chan, E.D.
2011Interleukin 37 expression protects mice from colitis.McNamee, E.N.; Masterson, J.C.; Jedlicka, P.; McManus, M.; Grenz, A.; Collins, C.B.; Nold, M.F.; Nold-Petry, C.; Bufler, P.; Dinarello, C.A.; Rivera-Nieves, J.
2011The rate of interleukin-1beta secretion in different myeloid cells varies with the extent of redox response to Toll-like receptor triggering.Carta, S.; Tassi, S.; Pettinati, I.; Delfino, L.; Dinarello, C.A.; Rubartelli, A.
2011Alpha-1 antitrypsin inhibits caspase-1 and protects from acute myocardial ischemia-reperfusion injury.Toldo, S.; Seropian, I.M.; Mezzaroma, E.; Tassell, B.W. Van; Salloum, F.N.; Lewis, E.C.; Voelkel, N.; Dinarello, C.A.; Abbate, A.
2011Pharmacokinetics, safety and inducible cytokine responses during a phase 1 trial of the oral histone deacetylase inhibitor ITF2357 (givinostat).Furlan, A.; Monzani, V.; Reznikov, L.L.; Leoni, F.; Fossati, G.; Modena, D.; Mascagni, P.; Dinarello, C.A.
2011Lack of interleukin-1alpha or interleukin-1beta inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice.Kamari, Y.; Shaish, A.; Vax, E.; Shemesh, S.; Kandel-Kfir, M.; Arbel, Y.; Olteanu, S.; Barshack, I.; Dotan, S.; Voronov, E.; Dinarello, C.A.; Apte, R.N.; Harats, D.
2011IL-37: a new anti-inflammatory cytokine of the IL-1 family.Boraschi, D.; Lucchesi, D.; Hainzl, S.; Leitner, M.; Maier, E.; Mangelberger, D.; Oostingh, G.J.; Pfaller, T.; Pixner, C.; Posselt, G.; Italiani, P.; Nold, M.F.; Nold-Petry, C.A.; Bufler, P.; Dinarello, C.A.
2011Reduced atherosclerosis and inflammatory cytokines in apolipoprotein-E-deficient mice lacking bone marrow-derived interleukin-1alpha.Kamari, Y.; Shaish, A.; Shemesh, S.; Vax, E.; Grosskopf, I.; Dotan, S.; White, M.; Voronov, E.; Dinarello, C.A.; Apte, R.N.; Harats, D.
2011Tumour necrosis factor alpha-driven IL-32 expression in rheumatoid arthritis synovial tissue amplifies an inflammatory cascadeHeinhuis, B.; Koenders, M.M.J.F.; Riel, P.L.C.M. van; Loo, F.A.J. van de; Dinarello, C.A.; Netea, M.G.; Berg, W.B. van den; Joosten, L.A.B.
2011Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis.Moschen, A.R.; Fritz, T.; Clouston, A.D.; Rebhan, I.; Bauhofer, O.; Barrie, H.D.; Powell, E.E.; Kim, S.H.; Dinarello, C.A.; Bartenschlager, R.; Jonsson, J.R.; Tilg, H.
2010IL-1 family nomenclature.Dinarello, C.A.; Arend, W.; Sims, J.; Smith, D.; Blumberg, H.; O'Neill, L.; Goldbach-Mansky, R.; Pizarro, T.; Hoffman, H.; Bufler, P.; Nold, M.; Ghezzi, P.; Mantovani, A.; Garlanda, C.; Boraschi, D.; Rubartelli, A.; Netea, M.G.; Meer, J.W.M. van der; Joosten, L.A.B.; Mandrup-Poulsen, T.; Donath, M.; Lewis, E.; Pfeilschifter, J.; Martin, M.; Kracht, M.; Muehl, H.; Novick, D.; Lukic, M.; Conti, B.; Solinger, A.; Peyman, K.; Veerdonk, F.L. van de; Gabel, C.
2010Anti-inflammatory Agents: Present and Future.Dinarello, C.A.
2010IL-1: discoveries, controversies and future directions.Dinarello, C.A.
2010Role of IL-1beta in type 2 diabetes.Dinarello, C.A.; Donath, M.Y.; Mandrup-Poulsen, T.
2010Why not treat human cancer with interleukin-1 blockade?Dinarello, C.A.
2010IL-32gamma and Streptococcus pyogenes cell wall fragments synergise for IL-1-dependent destructive arthritis via upregulation of TLR-2 and NOD2.Heinhuis, B.; Koenders, M.M.J.F.; Loo, F.A.J. van de; Lent, P.L.E.M. van; Kim, S.H.; Dinarello, C.A.; Joosten, L.A.B.; Berg, W.B. van den
2010Reactive oxygen species-independent activation of the IL-1beta inflammasome in cells from patients with chronic granulomatous disease.Veerdonk, F.L. van de; Smeekens, S.P.; Joosten, L.A.B.; Kullberg, B.J.; Dinarello, C.A.; Meer, J.W.M. van der; Netea, M.G.
2010Differential susceptibility to lethal endotoxaemia in mice deficient in IL-1alpha, IL-1beta or IL-1 receptor type I.Joosten, L.A.B.; Veerdonk, F.L. van de; Vonk, A.G.; Boerman, O.C.; Keuter, M.; Fantuzzi, G.; Verschueren, I.; Poll, T. van der; Dinarello, C.A.; Kullberg, B.J.; Meer, J.W.M. van der; Netea, M.G.
2009Transcriptional and inflammasome-mediated pathways for the induction of IL-1beta production by Mycobacterium tuberculosis.Kleinnijenhuis, J.; Joosten, L.A.B.; Veerdonk, F.L. van de; Savage, N.; Crevel, R. van; Kullberg, B.J.; Ven, A.J.A.M. van der; Ottenhoff, T.H.; Dinarello, C.A.; Meer, J.W.M. van der; Netea, M.G.
2009Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages.Netea, M.G.; Nold-Petry, C.A.; Nold, M.F.; Joosten, L.A.B.; Opitz, B.; Meer, J.H. van der; Veerdonk, F.L. van de; Ferwerda, G.; Heinhuis, S.M.; Devesa, I.; Funk, C.J.; Mason, R.J.; Kullberg, B.J.; Rubartelli, A.; Meer, J.W.M. van der; Dinarello, C.A.
2009Modulation of muramyl dipeptide stimulation of cytokine production by blood components.Meer, J.H. van der; Netea, M.G.; Dinarello, C.A.
2009Bypassing pathogen-induced inflammasome activation for the regulation of interleukin-1beta production by the fungal pathogen Candida albicans.Veerdonk, F.L. van de; Joosten, L.A.B.; Devesa, I.; Mora-Montes, H.M.; Kanneganti, T.D.; Dinarello, C.A.; Meer, J.W.M. van der; Gow, N.A.; Kullberg, B.J.; Netea, M.G.
2009Inflammatory arthritis in caspase 1 gene-deficient mice: contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1beta.Joosten, L.A.B.; Netea, M.G.; Fantuzzi, G.; Koenders, M.I.; Helsen, M.M.A.; Sparrer, H.; Pham, C.T.; Meer, J.W.M. van der; Dinarello, C.A.; Berg, W.B. van den
2008Interleukin-32 induces the differentiation of monocytes into macrophage-like cells.Netea, M.G.; Lewis, E.C.; Azam, T.; Joosten, L.A.B.; Jaekal, J.; Bae, S.Y.; Dinarello, C.A.; Kim, S.H.
2007Individual LPS responsiveness depends on the variation of Toll-like receptor (TLR) expression levelJaekal, J.; Abraham, E.; Azam, T.; Netea, M.G.; Dinarello, C.A.; Lim, J.S.; Yang, Y.; Yoon, D.Y.; Kim, S.H.
2006Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance.Netea, M.G.; Joosten, L.A.B.; Lewis, E.; Jensen, D.R.; Voshol, P.J.; Kullberg, B.J.; Tack, C.J.J.; Krieken, H. van; Kim, S.H.; Stalenhoef, A.F.H.; Loo, F.A.J. van de; Verschueren, I.; Pulawa, L.; Akira, S.; Eckel, R.H.; Dinarello, C.A.; Berg, W.B. van den; Meer, J.W.M. van der
2006Mycobacterium tuberculosis induces interleukin-32 production through a caspase- 1/IL-18/interferon-gamma-dependent mechanismNetea, M.G.; Azam, T.; Lewis, E.C.; Joosten, L.A.B.; Wang, M.; Langenberg, D.; Meng, X.; Chan, E.D.; Yoon, D.Y.; Ottenhoff, T.H.M.; Kim, S.H.; Dinarello, C.A.
2006Triggering receptor expressed on myeloid cells-1 (TREM-1) amplifies the signals induced by the NACHT-LRR (NLR) pattern recognition receptors.Netea, M.G.; Azam, T.; Ferwerda, G.; Girardin, S.E.; Kim, S.H.; Dinarello, C.A.
2006IL-32, a proinflammatory cytokine in rheumatoid arthritis.Joosten, L.A.B.; Netea, M.G.; Kim, S.H.; Yoon, D.Y.; Oppers-Walgreen, B.; Radstake, T.R.D.J.; Barrera, P.; Loo, F.A.J. van de; Dinarello, C.A.; Berg, W.B. van den
2005Interleukin-18 does not modulate the acute-phase response.Stuyt, R.J.L.; Netea, M.G.; Verschueren, C.M.M.; Dinarello, C.A.; Kullberg, B.J.; Meer, J.W.M. van der
2005IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism.Netea, M.G.; Azam, T.; Ferwerda, G.; Girardin, S.E.; Walsh, M.; Park, J.S.; Abraham, E.; Kim, J.M.; Yoon, D.Y.; Dinarello, C.A.; Kim, S.H.
2004Chlamydia pneumoniae stimulates IFN-gamma synthesis through MyD88-dependent, TLR2- and TLR4-independent induction of IL-18 releaseNetea, M.G.; Kullberg, B.J.; Jacobs, L.E.H.; Verver-Jansen, T.J.G.; Ven-Jongekrijg, J. van der; Galama, J.M.D.; Stalenhoef, A.F.H.; Dinarello, C.A.; Meer, J.W.M. van der

1 2 next

 

  DSpace Software Copyright © 2002-2011  Duraspace - Feedback